The store will not work correctly when cookies are disabled.
2-Amino-8-bromo-9-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one
ID: ALA3143046
Cas Number: 13389-03-2
PubChem CID: 135437126
Product Number: B122946, Order Now?
Max Phase: Preclinical
Molecular Formula: C10H12BrN5O4
Molecular Weight: 346.14
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(O)c2nc(Br)n([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1
Standard InChI: InChI=1S/C10H12BrN5O4/c11-9-13-6-7(14-10(12)15-8(6)19)16(9)5-1-3(18)4(2-17)20-5/h3-5,17-18H,1-2H2,(H3,12,14,15,19)/t3-,4+,5+/m0/s1
Standard InChI Key: MKDXZFVCXWXGBQ-VPENINKCSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
2.9046 -1.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1200 -0.9284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9046 -2.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6351 -1.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1200 -2.2633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6191 -0.7708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8651 -0.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6191 -2.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3336 -2.0083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3336 -1.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3500 0.5237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0804 0.1112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8651 1.1911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0804 0.9362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6191 -3.2458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8101 -1.5958 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
5.0480 -0.7708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4130 1.4211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1200 1.9757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5680 2.5888 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 1 0
5 3 1 0
6 1 2 0
7 2 1 1
8 3 2 0
9 10 2 0
10 6 1 0
11 7 1 0
12 7 1 0
13 11 1 0
14 12 1 0
15 8 1 0
16 4 1 0
17 10 1 0
14 18 1 6
13 19 1 1
20 19 1 0
5 4 2 0
9 8 1 0
14 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.14 | Molecular Weight (Monoisotopic): 345.0073 | AlogP: -0.48 | #Rotatable Bonds: 2 |
Polar Surface Area: 139.54 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.43 | CX Basic pKa: ┄ | CX LogP: 0.25 | CX LogD: 0.25 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.53 | Np Likeness Score: 0.66 |
References
1. Lin TS, Cheng JC, Ishiguro K, Sartorelli AC.. (1985) 8-Substituted guanosine and 2'-deoxyguanosine derivatives as potential inducers of the differentiation of Friend erythroleukemia cells., 28 (9): [PMID:3861870] [10.1021/jm00147a012] |